116 related articles for article (PubMed ID: 24759295)
1. In brief: enteric-coated aspirin as an antiplatelet drug.
Med Lett Drugs Ther; 2014 Apr; 56(1441):36. PubMed ID: 24759295
[No Abstract] [Full Text] [Related]
2. Enteric coated aspirin.
Grossman CM
Am J Med; 2007 Apr; 120(4):e9. PubMed ID: 17398216
[No Abstract] [Full Text] [Related]
3. Is enteric aspirin safer than regular aspirin?
Johns Hopkins Med Lett Health After 50; 2013 Aug; 25(7):7. PubMed ID: 24386685
[No Abstract] [Full Text] [Related]
4. Impact of a fixed-dose combination of naproxen and esomeprazole magnesium on serum thromboxane B2 inhibition by low-dose aspirin over 5 days in healthy adults: a phase I, randomized, double-blind, placebo-controlled, noninferiority trial.
Angiolillo DJ; Hwang C; Datto C; Desai B; Sostek M
Clin Ther; 2011 Dec; 33(12):1883-93. PubMed ID: 22078153
[TBL] [Abstract][Full Text] [Related]
5. Low-dose enteric-coated aspirin as an antiplatelet preparation.
McLeod LJ; Roberts MS; Seville PR
Med J Aust; 1988 Feb; 148(4):207. PubMed ID: 3340049
[No Abstract] [Full Text] [Related]
6. Enteric coating can lead to reduced antiplatelet effect of low-dose acetylsalicylic acid.
Haastrup PF; Grønlykke T; Jarbøl DE
Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):212-5. PubMed ID: 25469781
[TBL] [Abstract][Full Text] [Related]
7. Letter by Fisher and Johns regarding article, "Variable platelet response to aspirin and clopidogrel in atherothrombotic disease".
Fisher M; Johns T
Circulation; 2007 Nov; 116(19):e521. PubMed ID: 17984385
[No Abstract] [Full Text] [Related]
8. Anti-platelet effects of 100 mg alternate day oral aspirin: a randomized, double-blind, placebo-controlled trial of regular and enteric coated formulations in men and women.
Ridker PM; Hennekens CH; Tofler GH; Lipinska I; Buring JE
J Cardiovasc Risk; 1996 Apr; 3(2):209-12. PubMed ID: 8836865
[TBL] [Abstract][Full Text] [Related]
9. Aspirin dose do's and don'ts.
Johns Hopkins Med Lett Health After 50; 2007 Oct; 19(8):1-2. PubMed ID: 18229415
[No Abstract] [Full Text] [Related]
10. [Effect of enteric-coated tablets of acetylsalicylic acid on platelet function].
Nilsen DW; Thorsen LI; Haga AK; Gamst ON
Tidsskr Nor Laegeforen; 1986 Jun; 106(16):1385-7. PubMed ID: 3750293
[No Abstract] [Full Text] [Related]
11. Aspirin: expectations and limitations.
Rao GH
J Assoc Physicians India; 2008 May; 56():317-9. PubMed ID: 18700637
[No Abstract] [Full Text] [Related]
12. Who needs to be taking aspirin for cardiovascular protection? Studies conflict about the benefits for women.
Harv Health Lett; 2007 Jun; 32(8):4-5. PubMed ID: 17639622
[No Abstract] [Full Text] [Related]
13. Concomitant use of buffered and enteric-coated low-dose aspirin products and antisecretory drugs.
Takada M; Fukumoto K; Shibakawa M
J Clin Pharm Ther; 2004 Apr; 29(2):183-7. PubMed ID: 15068408
[TBL] [Abstract][Full Text] [Related]
14. Spaced administration of PA32540 and clopidogrel results in greater platelet inhibition than synchronous administration of enteric-coated aspirin and enteric-coated omeprazole and clopidogrel.
Gurbel PA; Bliden KP; Fort JG; Jeong YH; Shuldiner A; Chai S; Gesheff T; Antonino M; Gesheff M; Zhang Y; Tantry US
Am Heart J; 2013 Feb; 165(2):176-82. PubMed ID: 23351820
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet effect of aspirin--need for further research.
Mittal SR
J Assoc Physicians India; 2001 Apr; 49():493. PubMed ID: 11762631
[No Abstract] [Full Text] [Related]
16. Influence of low dose enteric-coated aspirin on platelet function.
Rao GH; Rao AS; White JG
Indian Heart J; 1992; 44(6):365-70. PubMed ID: 1307083
[TBL] [Abstract][Full Text] [Related]
17. Aspirin resistance: is it real? Is it clinically significant?
Dalen JE
Am J Med; 2007 Jan; 120(1):1-4. PubMed ID: 17208069
[No Abstract] [Full Text] [Related]
18. Variability in platelet response to a single daily dose of 150 mg enteric coated aspirin in a high risk population.
Mardikar H; Deo D; Deshpande N; Mardikar M; Ghosh A; Munot K; Steinhubl S; Mukherjee D
J Assoc Physicians India; 2008 May; 56():321-4. PubMed ID: 18700638
[TBL] [Abstract][Full Text] [Related]
19. Insights into the inhibition of platelet activation by omega-3 polyunsaturated fatty acids: beyond aspirin and clopidogrel.
Cohen MG; Rossi JS; Garbarino J; Bowling R; Motsinger-Reif AA; Schuler C; Dupont AG; Gabriel D
Thromb Res; 2011 Oct; 128(4):335-40. PubMed ID: 21621252
[TBL] [Abstract][Full Text] [Related]
20. Post-PCI fatal bleeding in aspirin and clopidogrel hyper responder: shifting from antiplatelet resistance to bleeding risk assessment?
Cuisset T; Frere C; Quilici J; Uhry S; Alessi MC; Bonnet JL
Int J Cardiol; 2010 Jan; 138(2):212-3. PubMed ID: 18707772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
